Gastric Electrical Stimulation for Treatment of Refractory Gastroparesis: the Current Approach to Management.

Abdominal pain Gastric electrical stimulation Gastroparesis Motility disorders Nausea Vomiting

Journal

Current gastroenterology reports
ISSN: 1534-312X
Titre abrégé: Curr Gastroenterol Rep
Pays: United States
ID NLM: 100888896

Informations de publication

Date de publication:
22 Jan 2021
Historique:
accepted: 29 12 2020
entrez: 23 1 2021
pubmed: 24 1 2021
medline: 21 9 2021
Statut: epublish

Résumé

Gastroparesis is one of the more challenging entities in the landscape of gastroenterology, posing difficulties for both patients and physicians with regard to effective management and therapies. In this article, we reviewed various gastroparesis treatment options, with an emphasis on gastric electrical stimulation (GES). GES has demonstrated a significant reduction of cardinal symptoms in refractory gastroparetic patients, particularly nausea and vomiting, across multiple studies. However, GES has not been shown to conclusively decrease gastric emptying time in these patients. Such finding has led the investigators to analyze the impact of combining GES with pyloroplasty. While this treatment pathway is nascent, its results thus far reveal an amplified improvement of gastroparesis symptomatology in addition to significant reduction of gastric transit, compared to GES by itself. Limited treatment choices are available for refractory gastroparesis. Combining GES with pyloroplasty holds promise but requires further assessment in large-scale trials to fully evaluate the risks and benefits.

Identifiants

pubmed: 33483775
doi: 10.1007/s11894-020-00803-0
pii: 10.1007/s11894-020-00803-0
pmc: PMC7822763
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2

Auteurs

Aaron Shanker (A)

Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.

Mohammad Bashashati (M)

Division of Gastroenterology, Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.

Ali Rezaie (A)

GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Ali.rezaie@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH